Metabolic syndrome and smoking are associated with persistence of nocturia after transurethral resection of the prostate.
Cosimo De NunzioGiorgia TemaRiccardo LombardoAntonio CicioneAntonio NacchiaSimone D'AnnunzioLuca SarchiFlavia ProiettiAldo BrassettiAndrea TubaroPublished in: Neurourology and urodynamics (2019)
In our single-center study, MetS and smoking increased the risk of moderate/severe persistent nocturia after TURP in patients with LUTS-BPE. Although these results should be confirmed, and the pathophysiology is yet to be completely understood, counseling smokers and MetS patients about the risk of postoperative persistent nocturia is warranted.
Keyphrases
- benign prostatic hyperplasia
- lower urinary tract symptoms
- smoking cessation
- metabolic syndrome
- end stage renal disease
- prostate cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- patients undergoing
- prognostic factors
- early onset
- cardiovascular disease
- insulin resistance
- adipose tissue
- skeletal muscle
- patient reported
- human immunodeficiency virus
- cardiovascular risk factors